PubMed HealthSearch

PubMed · 53262

Recognitive specificity of human cytotoxic T lymphocytes. I. Antigen-specific inhibition of human cell-mediated lympholysis.

Abstract

The specificity of antigen recognition by in vitro sensitized human cytotoxic T lymphocytes (CTLs) has been studied using a sensitive cell-mediated lympholysis (CML) assay. Frequently, high levels of cytotoxicity are observed on third-party targets unrelated to sensitizing or responding cells; however, no cytotoxicity differing significantly from zero has been observed on targets autologous to the responding CTLs. This "cross-killing" of third-party target cells has been observed when stimulating and third-party cells bear no cross-reacting serologically defined (SD) antigens, thought to be the target antigens recognized by CTLs. CML-blocking studies, using unlabeled normal human lymphocytes to inhibit 51Cr release from radiolabeled target cells, have shown that cross-killing, even in the absence of shared SD determinants, results from CTLs recognizing antigens shared by the third-party targets and the initial stimulating population. Furthermore, these antigens have been mapped to the major histocompatibility complex (MHC). The ability of human CTLs to specifically recognize MHC-controlled antigens not detected serologically suggests that SD antigens may be recognized differently by alloantisera and CTLs, or that MHC antigens other than SD may be the targets of CTLs in CML.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P M Sondel, F H Bach. 1975-12-01. Recognitive specificity of human cytotoxic T lymphocytes. I. Antigen-specific inhibition of human cell-mediated lympholysis.. https://doi.org/10.1084/jem.142.6.1339

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Specific and nonspecific cytotoxicity of leukocytes from human renal allograft recipients against donor fibroblasts.

A microcytotoxicity assay was used to search for cell-mediated cytotoxicity, serum-blocking factors, and antibody-dependent cell-mediated cytotoxicity (ADCC) against fibroblasts of donor origin in 19 human renal allograft recipients. Peripheral mononuclear cells (PMC) were frequently cytotoxic when they were obtained within 6 days prior to rejection, following sustained rejections, and within 1 month after removal of rejected grafts, but the toxicity was usually nonspecific. Recipient PMC were noncytotoxic when they were obtained within 6 days after the onset of an acute reversed rejection and during quiescent intervals when there was no evidence of rejection within 6 days before or after the assay. These data suggest that, regardless of its lack of specificity, there is some relationship between cytotoxicity of recipient PMC and allograft rejection. In none of 69 post-transplant serum samples was ADCC against donor target cells detected with the microcytotoxicity assay.

Cytotoxicity Tests, Immunologic

Lymphocyte subpopulations in man: characterization of human killer cells against allogeneic targets sensitized with HLA antibodies.

Human killer cells mediating antibody-dependent cytotoxicity against allogeneic lymphoblasts presensitized with HLA antibodies have been studied by rosette fractionation experiments. Enriched and/or depleted cell suspensions have been tested in dose-response studies. Two different populations can act as killer cells. The major cytotoxic capacity is retained among T cells with high-avidity Fc receptors, whereas a minor cytotoxic capacity was found among non-T cells with high-avidity Fc receptors. These two populations have different dose-response curves, indicating different effector mechanisms.

Cytotoxicity Tests, Immunologic

A micromethod for prospectively testing lymphocyte-mediated cytotoxicity (LMC) using fresh or frozen cells labelled with a fluorescent dye.

A direct, specific and rapid method has been developed to prospectively evaluate lymphocyte mediated cytotoxicity (LMC) for kidney transplant recipients. Donor lymphocytes, labeled with fluorescein diacetate, were incubated in a microtest plate for 2 h with recipients' effector cells. The percentage of fluorescent cells in each well was estimated relative to controls using an inverted phase fluorescence microscope. Lymphocytes obtained from seven of 12 recipients post-transplantation exhibited positive reactions, fluorescence of labeled donor cells was reduced to 30-65% of that observed in controls, and these reactive patients required nephrectomies. The responses of the remaining five patients were negative. Tests with their donor cells showed 80-95% control fluorescence, with favorable transplant results. Six of 21 recipients evaluated prospectively required nephrectomies within 34 days post-transplantation. Three of these subjects showed 15-65% control fluorescence, a positive LMC response; the other three yielded negative LMC responses but required nephrectomies possibly due to renal ischemia prior to transplantation. The remaining 15 patients demonstrated 85-90% control fluorescence with graft function continuing for 17 to 270 days. The results from direct LMC tests with a fluorescent label indicate that the system is of value in predicting early rejection of renal allotransplants.

Cytotoxicity Tests, Immunologic